Stockscreener 앱 받기
22.59
1.83%
-0.42
시간 외 거래:
22.59
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ... - Yahoo Finance
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earning - GuruFocus.com
Kiniksa Pharm's Revenue Surges 67% in Q3 - The Motley Fool
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Gap Down to $24.04 on Oct 29 - GuruFocus.com
Kiniksa Pharmaceuticals Q3 2024 Earnings: EPS Miss, Revenue Beats Estimates with $112.2 Million - GuruFocus.com
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewswire
Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Exploring Kiniksa Pharmaceuticals's Earnings Expectations - Benzinga
What To Expect From Kiniksa Pharmaceuticals International PLC (K - GuruFocus.com
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning - GlobeNewswire
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis - StockTitan
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewswire
Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 - Investing.com India
Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 By Investing.com - Investing.com UK
High Growth Tech Stocks To Watch In October 2024 - Simply Wall St
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing' - Yahoo Finance
Baker Bros. Advisors LP Increases Stake in Kiniksa Pharmaceuticals - Yahoo Finance
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts - Defense World
Kiniksa Pharmaceuticals: Looking In On A Developing Growth Story (NASDAQ:KNSA) - Seeking Alpha
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis - The Manila Times
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa - GlobeNewswire
Kiniksa Pharmaceuticals COO sells shares worth over $437,000 By Investing.com - Investing.com Australia
Kiniksa Pharmaceuticals COO sells shares worth over $437,000 - Investing.com
Kiniksa Pharmaceuticals International Plc. (KNSA) looking to reclaim success with recent performance - SETE News
Rubric Capital Management LP Acquires 223,094 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Sold by Acadian Asset Management LLC - Defense World
Kiniksa stock draws buy at Jefferies (NASDAQ:KNSA) - Seeking Alpha
Insider Sale Alert: Kiniksa Pharmaceuticals International Plc. [KNSA] – Is it Time to sell? - Knox Daily
Kiniksa Pharmaceuticals exec sells over $1.7m in shares By Investing.com - Investing.com Australia
Kiniksa Pharmaceuticals exec sells over $1.7m in shares - Investing.com India
The Psychology of Kiniksa Pharmaceuticals International Plc. Inc. (KNSA) Price Performance: Understanding Market Sentiment - The InvestChronicle
Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock - Defense World
Kiniksa Pharmaceuticals COO sells shares worth over $470k - Investing.com
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference - GlobeNewswire
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 52-Week High at $27.96 - Defense World
KNSA (Kiniksa Pharmaceuticals International) Property, Plan - GuruFocus.com
Wells Fargo analysts initates an Overweight rating for Kiniksa Pharmaceuticals International Plc. (KNSA) - Knox Daily
Stocks of Kiniksa Pharmaceuticals International Plc. (KNSA) are poised to climb above their peers - SETE News
3 'Strong Buy' Small-Cap Stocks to Snag Now for a Soft Landing - Inkl
KNSA (Kiniksa Pharmaceuticals International) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com
KNSA (Kiniksa Pharmaceuticals International) Treasury Stock : $0.0 Mil (As of Jun. 2024) - GuruFocus.com
KNSA (Kiniksa Pharmaceuticals International) Revenue : $338.9 Mil (TTM As of Jun. 2024) - GuruFocus.com
KNSA (Kiniksa Pharmaceuticals International) EV-to-Revenue : 4.87 (As of Aug. 16, 2024) - GuruFocus.com
KNSA (Kiniksa Pharmaceuticals International) PE Ratio (TTM) : At Loss (As of Aug. 18, 2024) - GuruFocus.com
KNSA (Kiniksa Pharmaceuticals International) Repurchase of Stock : $-3.1 Mil (TTM As of Jun. 2024) - GuruFocus.com
Kiniksa Pharmaceuticals International Plc. [KNSA] Patel Sanj K sells 136,124 Shares for $3.49 million - Knox Daily
Kiniksa Pharmaceuticals International Plc. (KNSA) Becoming More Attractive for Investors - Knox Daily
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Surges 25% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp - Yahoo Finance
Market Momentum Report: Kiniksa Pharmaceuticals International Plc. (KNSA)’s Negative Close at 25.77 - The Dwinnex
A stock that deserves closer examination: Kiniksa Pharmaceuticals International Plc. (KNSA) - US Post News
Kiniksa Pharmaceuticals International Plc. [KNSA] Stock sold by Insider Patel Sanj K for $3.49 million - Knox Daily
Kiniksa Pharmaceuticals CFO sells over $600k in company shares - Investing.com India
Kiniksa Pharmaceuticals CEO sells over $3.4m in stock By Investing.com - Investing.com Canada
Kiniksa Pharmaceuticals CEO sells over $3.4m in stock - Investing.com India
0.42%
0.84%
자본화:
|
볼륨(24시간):